CeriBell Inc CBLL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $18.38
- Day Range
- $17.80–18.39
- 52-Week Range
- $10.87–24.31
- Bid/Ask
- $18.19 / $18.29
- Shares Outstanding
- 37.94M
- Market Cap
- $690.18M
- Volume/Avg
- 146,850 / 292,360
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 7.19
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 300
- Website
- https://www.ceribell.com
Valuation
|
Metric
|
CBLL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.97 |
Price/Sales | 7.19 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CBLL
|
|---|---|
Quick Ratio | 9.69 |
Current Ratio | 10.44 |
Interest Coverage | −31.58 |
Quick Ratio
CBLL
Profitability
|
Metric
|
CBLL
|
|---|---|
Return on Assets (Normalized) | −23.51% |
Return on Equity (Normalized) | −28.76% |
Return on Invested Capital (Normalized) | −24.35% |
Return on Assets
CBLL
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Gfbnxztw | Pqzndy | $159B | |||
| Stryker Corp
SYK
| Lnkdzwyhx | Kgp | $120B | |||
| Medtronic PLC
MDT
| Lfzcqfmzv | Qnqckn | $103B | |||
| Boston Scientific Corp
BSX
| Dtwpthw | Rmdkthh | $72B | |||
| Edwards Lifesciences Corp
EW
| Fsydkvbyj | Lxgjlp | $50B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Wpylhbwc | Sngp | $29B | |||
| DexCom Inc
DXCM
| Bdrkwqjd | Mgxgss | $29B | |||
| Koninklijke Philips NV ADR
PHG
| Yht | Vms | $26B | |||
| Steris PLC
STE
| Wggngvmk | Mdfpx | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| Vglyqznjn | Rny | $17B |
United States